$4.04 -0.06 (-1.46%)

Inventiva S.A. American Depository Shares (IVA)

🚫 Inventiva S.A. American Depository Shares does not pay dividends

Company News

Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)
GlobeNewswire Inc. • Inventiva • October 14, 2025

Inventiva filed a Form F-3 with the SEC to establish an At-the-Market (ATM) equity financing program allowing the company to issue and sell up to $100 million in American Depositary Shares to eligible investors, with proceeds intended to fund research, development, and working capital needs.

Preview: Inventiva's Earnings
Benzinga • Benzinga Staff Writer • September 26, 2025

Inventiva is set to announce quarterly earnings, with analysts estimating an EPS of $-0.41. The company's stock has performed positively, with a 213.67% increase over the past 52 weeks.

Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA)
Zacks Investment Research • Zacks Equity Research • June 18, 2024

Inventiva (IVA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
The Motley Fool • [email protected] (Keith Speights) • March 17, 2024

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.